glp 1 drugs and alcohol GLP-1s Hold Promise as Treatment for Use Disorder GLP-1 medications get at the
Description
After injection, Semaglutide GLP-1 binds to GLP-1 receptors in the pancreas and brain, triggering physiological changes that support weight loss

Horowitz et al

Supply : In 2025, supply bottlenecks will continue to ease following extensive efforts by Novo Nordisk and Lilly to step up manufacturing, with important implications for competitive dynamics: The large-scale opportunity for compounders will be closing

Funding The authors have no funding for this project to declare
